Literature DB >> 33320628

Recent Advances in the Regenerative Approaches for Traumatic Spinal Cord Injury: Materials Perspective.

Walaa A Abbas1, Maha E Ibrahim2, Manar El-Naggar1, Wessam A Abass3, Ibrahim H Abdullah1, Basem I Awad4, Nageh K Allam1.   

Abstract

Spinal cord injury (SCI) is a devastating health condition that may lead to permanent disabilities and death. Understanding the pathophysiological perspectives of traumatic SCI is essential to define mechanisms that can help in designing recovery strategies. Since central nervous system tissues are notorious for their deficient ability to heal, efforts have been made to identify solutions to aid in restoration of the spinal cord tissues and thus its function. The two main approaches proposed to address this issue are neuroprotection and neuro-regeneration. Neuroprotection involves administering drugs to restore the injured microenvironment to normal after SCI. As for the neuro-regeneration approach, it focuses on axonal sprouting for functional recovery of the injured neural tissues and damaged axons. Despite the progress made in the field, neural regeneration treatment after SCI is still unsatisfactory owing to the disorganized way of axonal growth and extension. Nanomedicine and tissue engineering are considered promising therapeutic approaches that enhance axonal growth and directionality through implanting or injecting of the biomaterial scaffolds. One of these recent approaches is nanofibrous scaffolds that are used to provide physical support to maintain directional axonal growth in the lesion site. Furthermore, these preferable tissue-engineered substrates can afford axonal regeneration by mimicking the extracellular matrix of the neural tissues in terms of biological, chemical, and architectural characteristics. In this review, we discuss the regenerative approach using nanofibrous scaffolds with a focus on their fabrication methods and their properties that define their functionality performed to heal the neural tissue efficiently.

Entities:  

Keywords:  central nervous system (CNS); electrospinning; nanofibers; scaffolds; self-assembly peptides (SAPs); spinal cord injury (SCI)

Mesh:

Substances:

Year:  2020        PMID: 33320628     DOI: 10.1021/acsbiomaterials.0c01074

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  6 in total

1.  Construction of a niche-specific spinal white matter-like tissue to promote directional axon regeneration and myelination for rat spinal cord injury repair.

Authors:  Bi-Qin Lai; Yu-Rong Bai; Wei-Tao Han; Bao Zhang; Shu Liu; Jia-Hui Sun; Jia-Lin Liu; Ge Li; Xiang Zeng; Ying Ding; Yuan-Huan Ma; Ling Zhang; Zheng-Hong Chen; Jun Wang; Yuan Xiong; Jin-Hua Wu; Qi Quan; Ling-Yan Xing; Hong-Bo Zhang; Yuan-Shan Zeng
Journal:  Bioact Mater       Date:  2021-10-20

Review 2.  Reverse Adverse Immune Microenvironments by Biomaterials Enhance the Repair of Spinal Cord Injury.

Authors:  Hengyi Wang; Yuanliang Xia; Baoqin Li; Yuehong Li; Changfeng Fu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 3.  Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway.

Authors:  Bin Lv; Naiting Shen; Zhangrong Cheng; Yuhang Chen; Hua Ding; Jishan Yuan; Kangchen Zhao; Yukun Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-29

Review 4.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

Review 5.  Development and Advantages of Biodegradable PHA Polymers Based on Electrospun PHBV Fibers for Tissue Engineering and Other Biomedical Applications.

Authors:  Łukasz Kaniuk; Urszula Stachewicz
Journal:  ACS Biomater Sci Eng       Date:  2021-10-14

Review 6.  Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury.

Authors:  Tianyi Liu; Wenhao Zhu; Xiaoyu Zhang; Chuan He; Xiaolong Liu; Qiang Xin; Kexin Chen; Haifeng Wang
Journal:  Biomed Res Int       Date:  2022-08-08       Impact factor: 3.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.